• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正性肌力作用的机制。

Mechanisms of positive inotropic effects.

作者信息

Scholz H

机构信息

Abteilung Allgemeine Pharmakologie, Universitäts-Krankenhaus Eppendorf, Hamburg, FRG.

出版信息

Basic Res Cardiol. 1989;84 Suppl 1:3-7. doi: 10.1007/BF02650341.

DOI:10.1007/BF02650341
PMID:2554873
Abstract

This review deals with the principal mechanisms which are known to play a role in positive inotropism: 1) The myoplasmic Ca2+ concentration may be increased by increases in cyclic AMP. Beside receptor-mediated stimulation (isoprenaline) or direct stimulation (forskolin) of the adenylate cyclase, the cyclic AMP may be increased by phosphodiesterase inhibition; 2) Cyclic AMP-independent activation of Ca2+ channels can be brought about by alpha-adrenergic agents (phenylephrine) or so-called calcium agonists; 3) Only a small increase in myoplasmic Na+ concentration can greatly enhance the force of contraction by an increase in the intracellular Ca2+ concentration. This is possible by inhibition of the Na+/K+-ATPase (glycosides) or by prolongation of the open state of Na+ channels (DPI 201-106); 4) A direct inhibition of the Na+/Ca2+ exchange has been discussed for amiloride; 5) A prolongation of the action potential induced by K+ channel-inhibiting agents such as 4-amino-pyridine may increase the myoplasmic Ca2+ concentration by a prolongation of the slow Ca2+ inward current; 6) An increased Ca2+ sensitivity of the contractile proteins has been demonstrated for a number of compounds in vitro; the contribution of such an effect to the overall positive inotropism is unknown because a calcium sensitizer without any effects on calcium or sodium movements is not yet available.

摘要

本综述探讨了已知在正性肌力作用中发挥作用的主要机制

1)环磷酸腺苷(cAMP)增加可使肌浆内钙离子浓度升高。除了通过受体介导刺激(异丙肾上腺素)或直接刺激(福斯可林)腺苷酸环化酶外,抑制磷酸二酯酶也可使cAMP增加;2)α-肾上腺素能药物(去氧肾上腺素)或所谓的钙激动剂可引起不依赖cAMP的钙通道激活;3)肌浆内钠离子浓度仅小幅升高,即可通过增加细胞内钙离子浓度显著增强收缩力。这可通过抑制钠钾ATP酶(糖苷类)或延长钠通道开放状态(DPI 201-106)实现;4)已讨论过氨氯地平对钠钙交换的直接抑制作用;5)钾通道抑制剂(如4-氨基吡啶)诱导的动作电位延长,可能通过延长缓慢的钙内向电流增加肌浆内钙离子浓度;6)在体外已证实多种化合物可增加收缩蛋白对钙离子的敏感性;由于尚未找到对钙或钠转运无影响的钙敏化剂,这种效应在总体正性肌力作用中的贡献尚不清楚。

相似文献

1
Mechanisms of positive inotropic effects.正性肌力作用的机制。
Basic Res Cardiol. 1989;84 Suppl 1:3-7. doi: 10.1007/BF02650341.
2
Changes in intracellular Ca2+ mobilization and Ca2+ sensitization as mechanisms of action of physiological interventions and inotropic agents in intact myocardial cells.
Jpn Heart J. 1998 Jan;39(1):1-44. doi: 10.1536/ihj.39.1.
3
The two mechanisms of action of racemic cardiotonic EMD 53998, calcium sensitization and phosphodiesterase inhibition, reside in different enantiomers.消旋强心剂EMD 53998的两种作用机制,即钙致敏作用和磷酸二酯酶抑制作用,分别存在于不同的对映体中。
J Cardiovasc Pharmacol. 1993 Jun;21(6):883-92. doi: 10.1097/00005344-199306000-00006.
4
Amiloride: effects on myocardial force of contraction, sodium pump and Na+/Ca2+ exchange.阿米洛利:对心肌收缩力、钠泵及钠/钙交换的影响。
J Mol Cell Cardiol. 1986 Feb;18(2):177-88. doi: 10.1016/s0022-2828(86)80470-9.
5
The effects of milrinone and piroximone on intracellular calcium handling in working myocardium from the ferret.米力农和吡罗昔酮对雪貂工作心肌细胞内钙处理的影响。
Br J Pharmacol. 1985 May;85(1):97-108. doi: 10.1111/j.1476-5381.1985.tb08835.x.
6
Adenylyl cyclase-mediated effects contribute to increased Isoprenaline-induced cardiac contractility in TRPM4-deficient mice.腺苷酸环化酶介导的效应有助于增强异丙肾上腺素诱导的TRPM4基因敲除小鼠的心脏收缩力。
J Mol Cell Cardiol. 2014 Sep;74:307-17. doi: 10.1016/j.yjmcc.2014.06.007. Epub 2014 Jun 24.
7
Effects of alpha-adrenoceptor stimulation with phenylephrine in the presence of propranolol on force of contraction, slow inward current and cyclic AMP content in the bovine heart.在普萘洛尔存在的情况下,用去氧肾上腺素刺激α-肾上腺素受体对牛心脏收缩力、缓慢内向电流和环磷酸腺苷含量的影响。
Br J Pharmacol. 1984 May;82(1):223-32. doi: 10.1111/j.1476-5381.1984.tb16462.x.
8
Digoxin reduces beta-adrenergic contractile response in rabbit hearts. Ca(2+)-dependent inhibition of adenylyl cyclase activity via Na+/Ca2+ exchange.地高辛可降低兔心脏中的β-肾上腺素能收缩反应。通过钠/钙交换对腺苷酸环化酶活性进行钙依赖性抑制。
J Clin Invest. 1996 Jan 1;97(1):6-13. doi: 10.1172/JCI118407.
9
Forskolin, a new positive inotropic agent, and its influence on myocardial electrogenic cation movements.福司可林,一种新型正性肌力药,及其对心肌生电阳离子转运的影响。
J Cardiovasc Pharmacol. 1984 Jan-Feb;6(1):99-106.
10
Abnormal intracellular calcium handling, a major cause of systolic and diastolic dysfunction in ventricular myocardium from patients with heart failure.细胞内钙处理异常是心力衰竭患者心室心肌收缩和舒张功能障碍的主要原因。
Circulation. 1990 Feb;81(2 Suppl):III21-32.

引用本文的文献

1
Characterization of Stimulatory Action on Voltage-Gated Na Currents Caused by Omecamtiv Mecarbil, Known to Be a Myosin Activator.已知为肌球蛋白激活剂的omecamtiv mecarbil对电压门控钠电流的刺激作用特性
Biomedicines. 2023 May 3;11(5):1351. doi: 10.3390/biomedicines11051351.

本文引用的文献

1
Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts.衰竭的人类心脏中儿茶酚胺敏感性和β-肾上腺素能受体密度降低。
N Engl J Med. 1982 Jul 22;307(4):205-11. doi: 10.1056/NEJM198207223070401.
2
Cardioactive substances that prolong the open state of sodium channels.延长钠通道开放状态的心脏活性物质。
Rev Physiol Biochem Pharmacol. 1982;92:1-74. doi: 10.1007/BFb0030502.
3
Alpha-1 adrenoceptor-mediated positive inotropic effect and inositol trisphosphate increase in mammalian heart.α-1肾上腺素能受体介导的哺乳动物心脏正性肌力作用及三磷酸肌醇增加。
J Pharmacol Exp Ther. 1988 Apr;245(1):327-35.
4
Mechanism of action and cardiotonic activity of a new phosphodiesterase inhibitor, the benzimidazole derivative adibendan (BM 14.478), in guinea-pig hearts.新型磷酸二酯酶抑制剂苯并咪唑衍生物阿迪苯旦(BM 14.478)在豚鼠心脏中的作用机制及强心活性
Naunyn Schmiedebergs Arch Pharmacol. 1988 May;337(5):576-82. doi: 10.1007/BF00182735.
5
Deficient production of cyclic AMP: pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure.环磷酸腺苷生成不足:终末期心力衰竭患者收缩功能障碍重要病因的药理学证据
Circulation. 1987 Feb;75(2):331-9. doi: 10.1161/01.cir.75.2.331.
6
Phosphodiesterase-inhibiting properties of newer inotropic agents.新型正性肌力药物的磷酸二酯酶抑制特性。
Circulation. 1986 Mar;73(3 Pt 2):III99-108.